Career Center

SoMCC Event


Industry Insights with Geron: Embryonic Stem Cells (ESCs) - Progress and Promise

Date: June 9, 2009
Time: 12:00-1:30 PM
Location: Munzer Auditorium, Beckman Center

Sponsor: SoMCC

Event details:

Geron Corporation, a pioneering company at the forefront in stem cell research, has been granted permission by the FDA to conduct the world’s first clinical trial of human embryonic stem cells in spinal cord injury. What exactly are embryonic stem cells?  How do they differ from adult stem cells offered as alternatives by critics of ESCs?  Why are they controversial?  What is their potential in the new era of regenerative medicine?  When and how will it be realized?  How have policy and politics at the federal level affected progress toward cures?  How might the science fare in the wake of the Presidential election?  What has been and will be the impact of California’s Proposition 71, which made available $3 billion to advance research and development in the area?  These and other questions central to an imminent revolution in medicine will be discussed by Tom Okarma, president and CEO of Geron, Inc. based in Menlo Park, CA. 

About our Presenter:  
Dr. Okarma currently serves as president and CEO of Geron Corporation and affiliated companies.  He was the scientific founder, chairman and CEO of Applied Immune Sciences until it was acquired by Rhone-Poulenc Rorer in 1995.  He served as Chairman of the Board of Overseers of Dartmouth Medical School from 2001 to 2006 and currently serves on the board of BIO.  He was a member of the faculty at the Department of Medicine at Stanford University School of Medicine from 1985 to 1998.  Dr. Okarma holds a A.B. from Dartmouth College and a M.D. and Ph.D. from Stanford University. 

Fee: Free and open to Stanford ID holders.
Additional information and/or registration: RSVP required. Register online

Footer Links: